Global Zinc Deficiency Treatment Market

Zinc Deficiency Treatment Comprehensive Study by Type (Dietary Supplements, Oral Repletion Therapy), Application (Malnutrition, Anorexia, Oral Ulcers, Acne), Route of Administration (Oral Solids, Syrups, Intravenous Solutions), Distribution Channel (Online, Offline), Ingredients (Active ingredient (Zinc oxide), Inactive ingredients (Natural vanilla flavor, Glycerol, Carmellose sodium, others )), Dose Limit (1-3 years: 7mg, 4-8 years: 12mg, 9-13 years: 25mg, 14-18 years: 35mg, Others) Players and Region - Global Market Outlook to 2026

Zinc Deficiency Treatment Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Zinc Deficiency Treatment Market?

WHO and UNICEF have delivered updated proposals for the administration of looseness of the bowels focused on significantly lessening the quantity of passings because of the runs achievement in utilizing zinc supplementation notwithstanding rehydration treatment in the administration of diarrhoeal illnesses. Zinc is required for the appropriate development and support of the human body. It is found in a few frameworks and natural responses, and it is required for safe capacity, wound mending, blood thickening, thyroid capacity, and significantly more. Meats, fish, dairy items, nuts, vegetables, and entire grains offer generally elevated levels of zinc. Since zinc is so significant across various capacities, an insufficiency of zinc can cause a large group of issues. Individuals with zinc insufficiency can encounter vision and hearing misfortune, defenselessness to contaminations, postponed sexual development (in men), hindered development, balding, craving, and weight reduction, dry skin, and weakness. Appropriate zinc admission is particularly critical to the advancement of developing youngsters.

The market study is being classified by Type (Dietary Supplements and Oral Repletion Therapy), by Application (Malnutrition, Anorexia, Oral Ulcers and Acne) and major geographies with country level break-up.

BioCeuticals (Australia), Clinicians (United States), Walgreens (United States), Matsun Nutrition(United States), Nature's Life(United States), NutraChamps (Canada), Pfizer Inc. (United States), Metagenics, Inc. (Australia), Sandoz International GmbH (Germany) and Teva Pharmaceutical Industries Ltd. (Israel) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Twinlab Corporation (United States), Amway Corp. (United States) and DSM Nutritional Products (Netherlands).

The companies are exploring the market by adopting expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Zinc Deficiency Treatment market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Zinc Deficiency Treatment market by Type, Application and Region.

On the basis of geography, the market of Zinc Deficiency Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increasing use of Oral zinc supplementation for treating diarrhea in children
  • Asia-Pacific region dominates the market across the world with the escalating consumption

Market Trend
  • The emerging research and technological advancement in the field of zinc drops

Restraints
  • The adverse effect of zinc may cause nausea, vomiting, Itching others

Opportunities
  • Increasing Demand from health care Industry
  • High incidence of which can propel the demand for zinc supplements over the forecast period

Challenges
  • Lack of awareness





Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Zinc Deficiency Treatment Providers, Government Regulatory and Research Organizations and End-Use Industry

Report Objectives / Segmentation Covered

By Type
  • Dietary Supplements
  • Oral Repletion Therapy
By Application
  • Malnutrition
  • Anorexia
  • Oral Ulcers
  • Acne
By Route of Administration
  • Oral Solids
  • Syrups
  • Intravenous Solutions

By Distribution Channel
  • Online
  • Offline

By Ingredients
  • Active ingredient (Zinc oxide)
  • Inactive ingredients (Natural vanilla flavor, Glycerol, Carmellose sodium, others )

By Dose Limit
  • 1-3 years: 7mg
  • 4-8 years: 12mg
  • 9-13 years: 25mg
  • 14-18 years: 35mg
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing use of Oral zinc supplementation for treating diarrhea in children
      • 3.2.2. Asia-Pacific region dominates the market across the world with the escalating consumption
    • 3.3. Market Challenges
      • 3.3.1. Lack of awareness
    • 3.4. Market Trends
      • 3.4.1. The emerging research and technological advancement in the field of zinc drops
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Zinc Deficiency Treatment, by Type, Application, Route of Administration, Distribution Channel, Ingredients, Dose Limit and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Zinc Deficiency Treatment (Value)
      • 5.2.1. Global Zinc Deficiency Treatment by: Type (Value)
        • 5.2.1.1. Dietary Supplements
        • 5.2.1.2. Oral Repletion Therapy
      • 5.2.2. Global Zinc Deficiency Treatment by: Application (Value)
        • 5.2.2.1. Malnutrition
        • 5.2.2.2. Anorexia
        • 5.2.2.3. Oral Ulcers
        • 5.2.2.4. Acne
      • 5.2.3. Global Zinc Deficiency Treatment by: Distribution Channel (Value)
        • 5.2.3.1. Online
        • 5.2.3.2. Offline
      • 5.2.4. Global Zinc Deficiency Treatment by: Ingredients (Value)
        • 5.2.4.1. Active ingredient (Zinc oxide)
        • 5.2.4.2. Inactive ingredients (Natural vanilla flavor, Glycerol, Carmellose sodium, others )
      • 5.2.5. Global Zinc Deficiency Treatment Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Zinc Deficiency Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. BioCeuticals (Australia)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Clinicians (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Walgreens (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Matsun Nutrition(United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Nature's Life(United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. NutraChamps (Canada)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Pfizer Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Metagenics, Inc. (Australia)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sandoz International GmbH (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Teva Pharmaceutical Industries Ltd. (Israel)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Zinc Deficiency Treatment Sale, by Type, Application, Route of Administration, Distribution Channel, Ingredients, Dose Limit and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Zinc Deficiency Treatment (Value)
      • 7.2.1. Global Zinc Deficiency Treatment by: Type (Value)
        • 7.2.1.1. Dietary Supplements
        • 7.2.1.2. Oral Repletion Therapy
      • 7.2.2. Global Zinc Deficiency Treatment by: Application (Value)
        • 7.2.2.1. Malnutrition
        • 7.2.2.2. Anorexia
        • 7.2.2.3. Oral Ulcers
        • 7.2.2.4. Acne
      • 7.2.3. Global Zinc Deficiency Treatment by: Distribution Channel (Value)
        • 7.2.3.1. Online
        • 7.2.3.2. Offline
      • 7.2.4. Global Zinc Deficiency Treatment by: Ingredients (Value)
        • 7.2.4.1. Active ingredient (Zinc oxide)
        • 7.2.4.2. Inactive ingredients (Natural vanilla flavor, Glycerol, Carmellose sodium, others )
      • 7.2.5. Global Zinc Deficiency Treatment Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Zinc Deficiency Treatment: by Type(USD Million)
  • Table 2. Zinc Deficiency Treatment Dietary Supplements , by Region USD Million (2015-2020)
  • Table 3. Zinc Deficiency Treatment Oral Repletion Therapy , by Region USD Million (2015-2020)
  • Table 4. Zinc Deficiency Treatment: by Application(USD Million)
  • Table 5. Zinc Deficiency Treatment Malnutrition , by Region USD Million (2015-2020)
  • Table 6. Zinc Deficiency Treatment Anorexia , by Region USD Million (2015-2020)
  • Table 7. Zinc Deficiency Treatment Oral Ulcers , by Region USD Million (2015-2020)
  • Table 8. Zinc Deficiency Treatment Acne , by Region USD Million (2015-2020)
  • Table 9. Zinc Deficiency Treatment: by Distribution Channel(USD Million)
  • Table 10. Zinc Deficiency Treatment Online , by Region USD Million (2015-2020)
  • Table 11. Zinc Deficiency Treatment Offline , by Region USD Million (2015-2020)
  • Table 12. Zinc Deficiency Treatment: by Ingredients(USD Million)
  • Table 13. Zinc Deficiency Treatment Active ingredient (Zinc oxide) , by Region USD Million (2015-2020)
  • Table 14. Zinc Deficiency Treatment Inactive ingredients (Natural vanilla flavor, Glycerol, Carmellose sodium, others ) , by Region USD Million (2015-2020)
  • Table 15. South America Zinc Deficiency Treatment, by Country USD Million (2015-2020)
  • Table 16. South America Zinc Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 17. South America Zinc Deficiency Treatment, by Application USD Million (2015-2020)
  • Table 18. South America Zinc Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 19. South America Zinc Deficiency Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 20. South America Zinc Deficiency Treatment, by Ingredients USD Million (2015-2020)
  • Table 21. South America Zinc Deficiency Treatment, by Dose Limit USD Million (2015-2020)
  • Table 22. Brazil Zinc Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 23. Brazil Zinc Deficiency Treatment, by Application USD Million (2015-2020)
  • Table 24. Brazil Zinc Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 25. Brazil Zinc Deficiency Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 26. Brazil Zinc Deficiency Treatment, by Ingredients USD Million (2015-2020)
  • Table 27. Brazil Zinc Deficiency Treatment, by Dose Limit USD Million (2015-2020)
  • Table 28. Argentina Zinc Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 29. Argentina Zinc Deficiency Treatment, by Application USD Million (2015-2020)
  • Table 30. Argentina Zinc Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 31. Argentina Zinc Deficiency Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 32. Argentina Zinc Deficiency Treatment, by Ingredients USD Million (2015-2020)
  • Table 33. Argentina Zinc Deficiency Treatment, by Dose Limit USD Million (2015-2020)
  • Table 34. Rest of South America Zinc Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 35. Rest of South America Zinc Deficiency Treatment, by Application USD Million (2015-2020)
  • Table 36. Rest of South America Zinc Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 37. Rest of South America Zinc Deficiency Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 38. Rest of South America Zinc Deficiency Treatment, by Ingredients USD Million (2015-2020)
  • Table 39. Rest of South America Zinc Deficiency Treatment, by Dose Limit USD Million (2015-2020)
  • Table 40. Asia Pacific Zinc Deficiency Treatment, by Country USD Million (2015-2020)
  • Table 41. Asia Pacific Zinc Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 42. Asia Pacific Zinc Deficiency Treatment, by Application USD Million (2015-2020)
  • Table 43. Asia Pacific Zinc Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 44. Asia Pacific Zinc Deficiency Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 45. Asia Pacific Zinc Deficiency Treatment, by Ingredients USD Million (2015-2020)
  • Table 46. Asia Pacific Zinc Deficiency Treatment, by Dose Limit USD Million (2015-2020)
  • Table 47. China Zinc Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 48. China Zinc Deficiency Treatment, by Application USD Million (2015-2020)
  • Table 49. China Zinc Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 50. China Zinc Deficiency Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 51. China Zinc Deficiency Treatment, by Ingredients USD Million (2015-2020)
  • Table 52. China Zinc Deficiency Treatment, by Dose Limit USD Million (2015-2020)
  • Table 53. Japan Zinc Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 54. Japan Zinc Deficiency Treatment, by Application USD Million (2015-2020)
  • Table 55. Japan Zinc Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 56. Japan Zinc Deficiency Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 57. Japan Zinc Deficiency Treatment, by Ingredients USD Million (2015-2020)
  • Table 58. Japan Zinc Deficiency Treatment, by Dose Limit USD Million (2015-2020)
  • Table 59. India Zinc Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 60. India Zinc Deficiency Treatment, by Application USD Million (2015-2020)
  • Table 61. India Zinc Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 62. India Zinc Deficiency Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 63. India Zinc Deficiency Treatment, by Ingredients USD Million (2015-2020)
  • Table 64. India Zinc Deficiency Treatment, by Dose Limit USD Million (2015-2020)
  • Table 65. South Korea Zinc Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 66. South Korea Zinc Deficiency Treatment, by Application USD Million (2015-2020)
  • Table 67. South Korea Zinc Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 68. South Korea Zinc Deficiency Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 69. South Korea Zinc Deficiency Treatment, by Ingredients USD Million (2015-2020)
  • Table 70. South Korea Zinc Deficiency Treatment, by Dose Limit USD Million (2015-2020)
  • Table 71. Taiwan Zinc Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 72. Taiwan Zinc Deficiency Treatment, by Application USD Million (2015-2020)
  • Table 73. Taiwan Zinc Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 74. Taiwan Zinc Deficiency Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 75. Taiwan Zinc Deficiency Treatment, by Ingredients USD Million (2015-2020)
  • Table 76. Taiwan Zinc Deficiency Treatment, by Dose Limit USD Million (2015-2020)
  • Table 77. Australia Zinc Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 78. Australia Zinc Deficiency Treatment, by Application USD Million (2015-2020)
  • Table 79. Australia Zinc Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 80. Australia Zinc Deficiency Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 81. Australia Zinc Deficiency Treatment, by Ingredients USD Million (2015-2020)
  • Table 82. Australia Zinc Deficiency Treatment, by Dose Limit USD Million (2015-2020)
  • Table 83. Rest of Asia-Pacific Zinc Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 84. Rest of Asia-Pacific Zinc Deficiency Treatment, by Application USD Million (2015-2020)
  • Table 85. Rest of Asia-Pacific Zinc Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 86. Rest of Asia-Pacific Zinc Deficiency Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 87. Rest of Asia-Pacific Zinc Deficiency Treatment, by Ingredients USD Million (2015-2020)
  • Table 88. Rest of Asia-Pacific Zinc Deficiency Treatment, by Dose Limit USD Million (2015-2020)
  • Table 89. Europe Zinc Deficiency Treatment, by Country USD Million (2015-2020)
  • Table 90. Europe Zinc Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 91. Europe Zinc Deficiency Treatment, by Application USD Million (2015-2020)
  • Table 92. Europe Zinc Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 93. Europe Zinc Deficiency Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 94. Europe Zinc Deficiency Treatment, by Ingredients USD Million (2015-2020)
  • Table 95. Europe Zinc Deficiency Treatment, by Dose Limit USD Million (2015-2020)
  • Table 96. Germany Zinc Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 97. Germany Zinc Deficiency Treatment, by Application USD Million (2015-2020)
  • Table 98. Germany Zinc Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 99. Germany Zinc Deficiency Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 100. Germany Zinc Deficiency Treatment, by Ingredients USD Million (2015-2020)
  • Table 101. Germany Zinc Deficiency Treatment, by Dose Limit USD Million (2015-2020)
  • Table 102. France Zinc Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 103. France Zinc Deficiency Treatment, by Application USD Million (2015-2020)
  • Table 104. France Zinc Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 105. France Zinc Deficiency Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 106. France Zinc Deficiency Treatment, by Ingredients USD Million (2015-2020)
  • Table 107. France Zinc Deficiency Treatment, by Dose Limit USD Million (2015-2020)
  • Table 108. Italy Zinc Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 109. Italy Zinc Deficiency Treatment, by Application USD Million (2015-2020)
  • Table 110. Italy Zinc Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 111. Italy Zinc Deficiency Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 112. Italy Zinc Deficiency Treatment, by Ingredients USD Million (2015-2020)
  • Table 113. Italy Zinc Deficiency Treatment, by Dose Limit USD Million (2015-2020)
  • Table 114. United Kingdom Zinc Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 115. United Kingdom Zinc Deficiency Treatment, by Application USD Million (2015-2020)
  • Table 116. United Kingdom Zinc Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 117. United Kingdom Zinc Deficiency Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 118. United Kingdom Zinc Deficiency Treatment, by Ingredients USD Million (2015-2020)
  • Table 119. United Kingdom Zinc Deficiency Treatment, by Dose Limit USD Million (2015-2020)
  • Table 120. Netherlands Zinc Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 121. Netherlands Zinc Deficiency Treatment, by Application USD Million (2015-2020)
  • Table 122. Netherlands Zinc Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 123. Netherlands Zinc Deficiency Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 124. Netherlands Zinc Deficiency Treatment, by Ingredients USD Million (2015-2020)
  • Table 125. Netherlands Zinc Deficiency Treatment, by Dose Limit USD Million (2015-2020)
  • Table 126. Rest of Europe Zinc Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 127. Rest of Europe Zinc Deficiency Treatment, by Application USD Million (2015-2020)
  • Table 128. Rest of Europe Zinc Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 129. Rest of Europe Zinc Deficiency Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 130. Rest of Europe Zinc Deficiency Treatment, by Ingredients USD Million (2015-2020)
  • Table 131. Rest of Europe Zinc Deficiency Treatment, by Dose Limit USD Million (2015-2020)
  • Table 132. MEA Zinc Deficiency Treatment, by Country USD Million (2015-2020)
  • Table 133. MEA Zinc Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 134. MEA Zinc Deficiency Treatment, by Application USD Million (2015-2020)
  • Table 135. MEA Zinc Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 136. MEA Zinc Deficiency Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 137. MEA Zinc Deficiency Treatment, by Ingredients USD Million (2015-2020)
  • Table 138. MEA Zinc Deficiency Treatment, by Dose Limit USD Million (2015-2020)
  • Table 139. Middle East Zinc Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 140. Middle East Zinc Deficiency Treatment, by Application USD Million (2015-2020)
  • Table 141. Middle East Zinc Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 142. Middle East Zinc Deficiency Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 143. Middle East Zinc Deficiency Treatment, by Ingredients USD Million (2015-2020)
  • Table 144. Middle East Zinc Deficiency Treatment, by Dose Limit USD Million (2015-2020)
  • Table 145. Africa Zinc Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 146. Africa Zinc Deficiency Treatment, by Application USD Million (2015-2020)
  • Table 147. Africa Zinc Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 148. Africa Zinc Deficiency Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 149. Africa Zinc Deficiency Treatment, by Ingredients USD Million (2015-2020)
  • Table 150. Africa Zinc Deficiency Treatment, by Dose Limit USD Million (2015-2020)
  • Table 151. North America Zinc Deficiency Treatment, by Country USD Million (2015-2020)
  • Table 152. North America Zinc Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 153. North America Zinc Deficiency Treatment, by Application USD Million (2015-2020)
  • Table 154. North America Zinc Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 155. North America Zinc Deficiency Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 156. North America Zinc Deficiency Treatment, by Ingredients USD Million (2015-2020)
  • Table 157. North America Zinc Deficiency Treatment, by Dose Limit USD Million (2015-2020)
  • Table 158. United States Zinc Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 159. United States Zinc Deficiency Treatment, by Application USD Million (2015-2020)
  • Table 160. United States Zinc Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 161. United States Zinc Deficiency Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 162. United States Zinc Deficiency Treatment, by Ingredients USD Million (2015-2020)
  • Table 163. United States Zinc Deficiency Treatment, by Dose Limit USD Million (2015-2020)
  • Table 164. Canada Zinc Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 165. Canada Zinc Deficiency Treatment, by Application USD Million (2015-2020)
  • Table 166. Canada Zinc Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 167. Canada Zinc Deficiency Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 168. Canada Zinc Deficiency Treatment, by Ingredients USD Million (2015-2020)
  • Table 169. Canada Zinc Deficiency Treatment, by Dose Limit USD Million (2015-2020)
  • Table 170. Mexico Zinc Deficiency Treatment, by Type USD Million (2015-2020)
  • Table 171. Mexico Zinc Deficiency Treatment, by Application USD Million (2015-2020)
  • Table 172. Mexico Zinc Deficiency Treatment, by Route of Administration USD Million (2015-2020)
  • Table 173. Mexico Zinc Deficiency Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 174. Mexico Zinc Deficiency Treatment, by Ingredients USD Million (2015-2020)
  • Table 175. Mexico Zinc Deficiency Treatment, by Dose Limit USD Million (2015-2020)
  • Table 176. Company Basic Information, Sales Area and Its Competitors
  • Table 177. Company Basic Information, Sales Area and Its Competitors
  • Table 178. Company Basic Information, Sales Area and Its Competitors
  • Table 179. Company Basic Information, Sales Area and Its Competitors
  • Table 180. Company Basic Information, Sales Area and Its Competitors
  • Table 181. Company Basic Information, Sales Area and Its Competitors
  • Table 182. Company Basic Information, Sales Area and Its Competitors
  • Table 183. Company Basic Information, Sales Area and Its Competitors
  • Table 184. Company Basic Information, Sales Area and Its Competitors
  • Table 185. Company Basic Information, Sales Area and Its Competitors
  • Table 186. Zinc Deficiency Treatment: by Type(USD Million)
  • Table 187. Zinc Deficiency Treatment Dietary Supplements , by Region USD Million (2021-2026)
  • Table 188. Zinc Deficiency Treatment Oral Repletion Therapy , by Region USD Million (2021-2026)
  • Table 189. Zinc Deficiency Treatment: by Application(USD Million)
  • Table 190. Zinc Deficiency Treatment Malnutrition , by Region USD Million (2021-2026)
  • Table 191. Zinc Deficiency Treatment Anorexia , by Region USD Million (2021-2026)
  • Table 192. Zinc Deficiency Treatment Oral Ulcers , by Region USD Million (2021-2026)
  • Table 193. Zinc Deficiency Treatment Acne , by Region USD Million (2021-2026)
  • Table 194. Zinc Deficiency Treatment: by Distribution Channel(USD Million)
  • Table 195. Zinc Deficiency Treatment Online , by Region USD Million (2021-2026)
  • Table 196. Zinc Deficiency Treatment Offline , by Region USD Million (2021-2026)
  • Table 197. Zinc Deficiency Treatment: by Ingredients(USD Million)
  • Table 198. Zinc Deficiency Treatment Active ingredient (Zinc oxide) , by Region USD Million (2021-2026)
  • Table 199. Zinc Deficiency Treatment Inactive ingredients (Natural vanilla flavor, Glycerol, Carmellose sodium, others ) , by Region USD Million (2021-2026)
  • Table 200. South America Zinc Deficiency Treatment, by Country USD Million (2021-2026)
  • Table 201. South America Zinc Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 202. South America Zinc Deficiency Treatment, by Application USD Million (2021-2026)
  • Table 203. South America Zinc Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 204. South America Zinc Deficiency Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 205. South America Zinc Deficiency Treatment, by Ingredients USD Million (2021-2026)
  • Table 206. South America Zinc Deficiency Treatment, by Dose Limit USD Million (2021-2026)
  • Table 207. Brazil Zinc Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 208. Brazil Zinc Deficiency Treatment, by Application USD Million (2021-2026)
  • Table 209. Brazil Zinc Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 210. Brazil Zinc Deficiency Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 211. Brazil Zinc Deficiency Treatment, by Ingredients USD Million (2021-2026)
  • Table 212. Brazil Zinc Deficiency Treatment, by Dose Limit USD Million (2021-2026)
  • Table 213. Argentina Zinc Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 214. Argentina Zinc Deficiency Treatment, by Application USD Million (2021-2026)
  • Table 215. Argentina Zinc Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 216. Argentina Zinc Deficiency Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 217. Argentina Zinc Deficiency Treatment, by Ingredients USD Million (2021-2026)
  • Table 218. Argentina Zinc Deficiency Treatment, by Dose Limit USD Million (2021-2026)
  • Table 219. Rest of South America Zinc Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 220. Rest of South America Zinc Deficiency Treatment, by Application USD Million (2021-2026)
  • Table 221. Rest of South America Zinc Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 222. Rest of South America Zinc Deficiency Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 223. Rest of South America Zinc Deficiency Treatment, by Ingredients USD Million (2021-2026)
  • Table 224. Rest of South America Zinc Deficiency Treatment, by Dose Limit USD Million (2021-2026)
  • Table 225. Asia Pacific Zinc Deficiency Treatment, by Country USD Million (2021-2026)
  • Table 226. Asia Pacific Zinc Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 227. Asia Pacific Zinc Deficiency Treatment, by Application USD Million (2021-2026)
  • Table 228. Asia Pacific Zinc Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 229. Asia Pacific Zinc Deficiency Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 230. Asia Pacific Zinc Deficiency Treatment, by Ingredients USD Million (2021-2026)
  • Table 231. Asia Pacific Zinc Deficiency Treatment, by Dose Limit USD Million (2021-2026)
  • Table 232. China Zinc Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 233. China Zinc Deficiency Treatment, by Application USD Million (2021-2026)
  • Table 234. China Zinc Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 235. China Zinc Deficiency Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 236. China Zinc Deficiency Treatment, by Ingredients USD Million (2021-2026)
  • Table 237. China Zinc Deficiency Treatment, by Dose Limit USD Million (2021-2026)
  • Table 238. Japan Zinc Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 239. Japan Zinc Deficiency Treatment, by Application USD Million (2021-2026)
  • Table 240. Japan Zinc Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 241. Japan Zinc Deficiency Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 242. Japan Zinc Deficiency Treatment, by Ingredients USD Million (2021-2026)
  • Table 243. Japan Zinc Deficiency Treatment, by Dose Limit USD Million (2021-2026)
  • Table 244. India Zinc Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 245. India Zinc Deficiency Treatment, by Application USD Million (2021-2026)
  • Table 246. India Zinc Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 247. India Zinc Deficiency Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 248. India Zinc Deficiency Treatment, by Ingredients USD Million (2021-2026)
  • Table 249. India Zinc Deficiency Treatment, by Dose Limit USD Million (2021-2026)
  • Table 250. South Korea Zinc Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 251. South Korea Zinc Deficiency Treatment, by Application USD Million (2021-2026)
  • Table 252. South Korea Zinc Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 253. South Korea Zinc Deficiency Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 254. South Korea Zinc Deficiency Treatment, by Ingredients USD Million (2021-2026)
  • Table 255. South Korea Zinc Deficiency Treatment, by Dose Limit USD Million (2021-2026)
  • Table 256. Taiwan Zinc Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 257. Taiwan Zinc Deficiency Treatment, by Application USD Million (2021-2026)
  • Table 258. Taiwan Zinc Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 259. Taiwan Zinc Deficiency Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 260. Taiwan Zinc Deficiency Treatment, by Ingredients USD Million (2021-2026)
  • Table 261. Taiwan Zinc Deficiency Treatment, by Dose Limit USD Million (2021-2026)
  • Table 262. Australia Zinc Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 263. Australia Zinc Deficiency Treatment, by Application USD Million (2021-2026)
  • Table 264. Australia Zinc Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 265. Australia Zinc Deficiency Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 266. Australia Zinc Deficiency Treatment, by Ingredients USD Million (2021-2026)
  • Table 267. Australia Zinc Deficiency Treatment, by Dose Limit USD Million (2021-2026)
  • Table 268. Rest of Asia-Pacific Zinc Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 269. Rest of Asia-Pacific Zinc Deficiency Treatment, by Application USD Million (2021-2026)
  • Table 270. Rest of Asia-Pacific Zinc Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 271. Rest of Asia-Pacific Zinc Deficiency Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 272. Rest of Asia-Pacific Zinc Deficiency Treatment, by Ingredients USD Million (2021-2026)
  • Table 273. Rest of Asia-Pacific Zinc Deficiency Treatment, by Dose Limit USD Million (2021-2026)
  • Table 274. Europe Zinc Deficiency Treatment, by Country USD Million (2021-2026)
  • Table 275. Europe Zinc Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 276. Europe Zinc Deficiency Treatment, by Application USD Million (2021-2026)
  • Table 277. Europe Zinc Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 278. Europe Zinc Deficiency Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 279. Europe Zinc Deficiency Treatment, by Ingredients USD Million (2021-2026)
  • Table 280. Europe Zinc Deficiency Treatment, by Dose Limit USD Million (2021-2026)
  • Table 281. Germany Zinc Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 282. Germany Zinc Deficiency Treatment, by Application USD Million (2021-2026)
  • Table 283. Germany Zinc Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 284. Germany Zinc Deficiency Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 285. Germany Zinc Deficiency Treatment, by Ingredients USD Million (2021-2026)
  • Table 286. Germany Zinc Deficiency Treatment, by Dose Limit USD Million (2021-2026)
  • Table 287. France Zinc Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 288. France Zinc Deficiency Treatment, by Application USD Million (2021-2026)
  • Table 289. France Zinc Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 290. France Zinc Deficiency Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 291. France Zinc Deficiency Treatment, by Ingredients USD Million (2021-2026)
  • Table 292. France Zinc Deficiency Treatment, by Dose Limit USD Million (2021-2026)
  • Table 293. Italy Zinc Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 294. Italy Zinc Deficiency Treatment, by Application USD Million (2021-2026)
  • Table 295. Italy Zinc Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 296. Italy Zinc Deficiency Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 297. Italy Zinc Deficiency Treatment, by Ingredients USD Million (2021-2026)
  • Table 298. Italy Zinc Deficiency Treatment, by Dose Limit USD Million (2021-2026)
  • Table 299. United Kingdom Zinc Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 300. United Kingdom Zinc Deficiency Treatment, by Application USD Million (2021-2026)
  • Table 301. United Kingdom Zinc Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 302. United Kingdom Zinc Deficiency Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 303. United Kingdom Zinc Deficiency Treatment, by Ingredients USD Million (2021-2026)
  • Table 304. United Kingdom Zinc Deficiency Treatment, by Dose Limit USD Million (2021-2026)
  • Table 305. Netherlands Zinc Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 306. Netherlands Zinc Deficiency Treatment, by Application USD Million (2021-2026)
  • Table 307. Netherlands Zinc Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 308. Netherlands Zinc Deficiency Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 309. Netherlands Zinc Deficiency Treatment, by Ingredients USD Million (2021-2026)
  • Table 310. Netherlands Zinc Deficiency Treatment, by Dose Limit USD Million (2021-2026)
  • Table 311. Rest of Europe Zinc Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 312. Rest of Europe Zinc Deficiency Treatment, by Application USD Million (2021-2026)
  • Table 313. Rest of Europe Zinc Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 314. Rest of Europe Zinc Deficiency Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 315. Rest of Europe Zinc Deficiency Treatment, by Ingredients USD Million (2021-2026)
  • Table 316. Rest of Europe Zinc Deficiency Treatment, by Dose Limit USD Million (2021-2026)
  • Table 317. MEA Zinc Deficiency Treatment, by Country USD Million (2021-2026)
  • Table 318. MEA Zinc Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 319. MEA Zinc Deficiency Treatment, by Application USD Million (2021-2026)
  • Table 320. MEA Zinc Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 321. MEA Zinc Deficiency Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 322. MEA Zinc Deficiency Treatment, by Ingredients USD Million (2021-2026)
  • Table 323. MEA Zinc Deficiency Treatment, by Dose Limit USD Million (2021-2026)
  • Table 324. Middle East Zinc Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 325. Middle East Zinc Deficiency Treatment, by Application USD Million (2021-2026)
  • Table 326. Middle East Zinc Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 327. Middle East Zinc Deficiency Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 328. Middle East Zinc Deficiency Treatment, by Ingredients USD Million (2021-2026)
  • Table 329. Middle East Zinc Deficiency Treatment, by Dose Limit USD Million (2021-2026)
  • Table 330. Africa Zinc Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 331. Africa Zinc Deficiency Treatment, by Application USD Million (2021-2026)
  • Table 332. Africa Zinc Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 333. Africa Zinc Deficiency Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 334. Africa Zinc Deficiency Treatment, by Ingredients USD Million (2021-2026)
  • Table 335. Africa Zinc Deficiency Treatment, by Dose Limit USD Million (2021-2026)
  • Table 336. North America Zinc Deficiency Treatment, by Country USD Million (2021-2026)
  • Table 337. North America Zinc Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 338. North America Zinc Deficiency Treatment, by Application USD Million (2021-2026)
  • Table 339. North America Zinc Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 340. North America Zinc Deficiency Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 341. North America Zinc Deficiency Treatment, by Ingredients USD Million (2021-2026)
  • Table 342. North America Zinc Deficiency Treatment, by Dose Limit USD Million (2021-2026)
  • Table 343. United States Zinc Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 344. United States Zinc Deficiency Treatment, by Application USD Million (2021-2026)
  • Table 345. United States Zinc Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 346. United States Zinc Deficiency Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 347. United States Zinc Deficiency Treatment, by Ingredients USD Million (2021-2026)
  • Table 348. United States Zinc Deficiency Treatment, by Dose Limit USD Million (2021-2026)
  • Table 349. Canada Zinc Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 350. Canada Zinc Deficiency Treatment, by Application USD Million (2021-2026)
  • Table 351. Canada Zinc Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 352. Canada Zinc Deficiency Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 353. Canada Zinc Deficiency Treatment, by Ingredients USD Million (2021-2026)
  • Table 354. Canada Zinc Deficiency Treatment, by Dose Limit USD Million (2021-2026)
  • Table 355. Mexico Zinc Deficiency Treatment, by Type USD Million (2021-2026)
  • Table 356. Mexico Zinc Deficiency Treatment, by Application USD Million (2021-2026)
  • Table 357. Mexico Zinc Deficiency Treatment, by Route of Administration USD Million (2021-2026)
  • Table 358. Mexico Zinc Deficiency Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 359. Mexico Zinc Deficiency Treatment, by Ingredients USD Million (2021-2026)
  • Table 360. Mexico Zinc Deficiency Treatment, by Dose Limit USD Million (2021-2026)
  • Table 361. Research Programs/Design for This Report
  • Table 362. Key Data Information from Secondary Sources
  • Table 363. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Zinc Deficiency Treatment: by Type USD Million (2015-2020)
  • Figure 5. Global Zinc Deficiency Treatment: by Application USD Million (2015-2020)
  • Figure 6. Global Zinc Deficiency Treatment: by Distribution Channel USD Million (2015-2020)
  • Figure 7. Global Zinc Deficiency Treatment: by Ingredients USD Million (2015-2020)
  • Figure 8. South America Zinc Deficiency Treatment Share (%), by Country
  • Figure 9. Asia Pacific Zinc Deficiency Treatment Share (%), by Country
  • Figure 10. Europe Zinc Deficiency Treatment Share (%), by Country
  • Figure 11. MEA Zinc Deficiency Treatment Share (%), by Country
  • Figure 12. North America Zinc Deficiency Treatment Share (%), by Country
  • Figure 13. Global Zinc Deficiency Treatment share by Players 2020 (%)
  • Figure 14. Global Zinc Deficiency Treatment share by Players (Top 3) 2020(%)
  • Figure 15. Global Zinc Deficiency Treatment share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. BioCeuticals (Australia) Revenue, Net Income and Gross profit
  • Figure 18. BioCeuticals (Australia) Revenue: by Geography 2020
  • Figure 19. Clinicians (United States) Revenue, Net Income and Gross profit
  • Figure 20. Clinicians (United States) Revenue: by Geography 2020
  • Figure 21. Walgreens (United States) Revenue, Net Income and Gross profit
  • Figure 22. Walgreens (United States) Revenue: by Geography 2020
  • Figure 23. Matsun Nutrition(United States) Revenue, Net Income and Gross profit
  • Figure 24. Matsun Nutrition(United States) Revenue: by Geography 2020
  • Figure 25. Nature's Life(United States) Revenue, Net Income and Gross profit
  • Figure 26. Nature's Life(United States) Revenue: by Geography 2020
  • Figure 27. NutraChamps (Canada) Revenue, Net Income and Gross profit
  • Figure 28. NutraChamps (Canada) Revenue: by Geography 2020
  • Figure 29. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Pfizer Inc. (United States) Revenue: by Geography 2020
  • Figure 31. Metagenics, Inc. (Australia) Revenue, Net Income and Gross profit
  • Figure 32. Metagenics, Inc. (Australia) Revenue: by Geography 2020
  • Figure 33. Sandoz International GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Sandoz International GmbH (Germany) Revenue: by Geography 2020
  • Figure 35. Teva Pharmaceutical Industries Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 36. Teva Pharmaceutical Industries Ltd. (Israel) Revenue: by Geography 2020
  • Figure 37. Global Zinc Deficiency Treatment: by Type USD Million (2021-2026)
  • Figure 38. Global Zinc Deficiency Treatment: by Application USD Million (2021-2026)
  • Figure 39. Global Zinc Deficiency Treatment: by Distribution Channel USD Million (2021-2026)
  • Figure 40. Global Zinc Deficiency Treatment: by Ingredients USD Million (2021-2026)
  • Figure 41. South America Zinc Deficiency Treatment Share (%), by Country
  • Figure 42. Asia Pacific Zinc Deficiency Treatment Share (%), by Country
  • Figure 43. Europe Zinc Deficiency Treatment Share (%), by Country
  • Figure 44. MEA Zinc Deficiency Treatment Share (%), by Country
  • Figure 45. North America Zinc Deficiency Treatment Share (%), by Country
List of companies from research coverage that are profiled in the study
  • BioCeuticals (Australia)
  • Clinicians (United States)
  • Walgreens (United States)
  • Matsun Nutrition(United States)
  • Nature's Life(United States)
  • NutraChamps (Canada)
  • Pfizer Inc. (United States)
  • Metagenics, Inc. (Australia)
  • Sandoz International GmbH (Germany)
  • Teva Pharmaceutical Industries Ltd. (Israel)
Additional players considered in the study are as follows:
Twinlab Corporation (United States) , Amway Corp. (United States) , DSM Nutritional Products (Netherlands)
Select User Access Type

Key Highlights of Report


Jan 2021 201 Pages 78 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Zinc Deficiency Treatment Market Quantitative research analysis
Global Zinc Deficiency Treatment Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Increasing use of Oral zinc supplementation for treating diarrhea in children " is seen as one of major growth factors of Zinc Deficiency Treatment Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

Know More About Global Zinc Deficiency Treatment Market Report?

Have a Query? Click Here

Other Related Reports

Moderna Vaccine Comprehensive Study by End User (Laboratories, Hospitals, Diagnostic Centers and Clinics, Research Institutes, Others) Players and Region - Global Market Outlook to 2030
$ 3500
Alverine Citrate Comprehensive Study by Administration (Oral, Injection), Level (Mild, Moderate, Severe), End User (Adult, Children), Capsules (60 MG, 120 Mg, Others (300 Mg)) Players and Region - ...
$ 3500
Renal Cell Cancer Treatment Comprehensive Study by Type (Surgery, Radiation therapy, Chemotherapy, Immunotherapy, Targeted therapy, Others(Under Clinical trial)), Surgery types (Partial nephrectomy, ...
$ 3750
Shigella Vaccines Comprehensive Study by Application (Hospitals, Clinics, Academic and Research, Others), Species (Shigella Sonnei, Shigella Flexneri, Shigella Boydii, Shigella Dysenteriae) Players a...
$ 3500
Hard Capsule Gelatin Comprehensive Study by Type (Transparent, Translucent, Opaque), Application (Preparation of Drugs, Preparation of Health Care Products), Excipients used (Powder filled capsule, ...
$ 3750
Natural Cold Remedies Comprehensive Study by Type (Eucalyptus, Ashwagandha, Vitamin C, Nasal Irrigation, Herbal Supplements & Vitamins, Others), Application (Home, Ayurvedic Clinic), Form (Tablets, S...
$ 3450